Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

API Manufacturing: SOP for Phase Separation Techniques – V 2.0

Posted on By

API Manufacturing: SOP for Phase Separation Techniques – V 2.0

Standard Operating Procedure for Phase Separation Techniques in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/025/2025
Supersedes SOP/API/025/2022
Page No. Page 1 of 10
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To establish a procedure for conducting phase separation efficiently and safely in API manufacturing, including the handling of aqueous-organic and solvent-based separations using decanters, separators, or phase separation tanks.

2. Scope

This SOP applies to all two-phase liquid separation activities carried out in production reactors or dedicated phase separation tanks as part of the synthesis or purification process in API manufacturing.

3. Responsibilities

  • Production Operator: Execute phase separation as per the BMR and record relevant parameters.
  • Process Engineer: Verify layer densities and interface levels; ensure process efficiency.
  • QA Personnel: Review logbooks and monitor compliance to phase separation controls.
See also  API Manufacturing: SOP for Vendor Qualification and Approval Process - V 2.0

4. Accountability

The Production Manager is accountable for the execution of phase separation operations, while the QA Head ensures documentation and compliance.

5. Procedure

5.1 Prerequisites

  1. Review the BMR for:
    • Nature of the phases (aqueous/organic)
    • Specific gravity of each layer
    • Separation equipment (decanter, phase separator)
  2. Verify:
    • Integrity and cleanliness of the separation vessel
    • Calibration status of interface level sensor (if automated)
    • Drain valve operation

5.2 Execution of Phase Separation

  1. Allow the reaction mass or mixture to settle undisturbed for the required time (typically 30–60 minutes unless otherwise specified).
  2. Use visual level observation, interface meter, or gravity difference to identify layers.
  3. Open the bottom valve slowly to allow the heavier phase (typically aqueous) to drain into the collection vessel.
  4. Close the valve as soon as the interface is reached. Collect a sample from each phase for identification (Annexure-1).
  5. Repeat for top phase collection into a separate container, label appropriately.
  6. If required, repeat phase separation after washing or re-extraction steps.
See also  API Manufacturing: SOP for Raw Material Sampling Procedure - V 2.0

5.3 Safety and Environmental Considerations

  1. Use flameproof motors and grounding in case of flammable solvents.
  2. Vent vapors to scrubber if volatile components are involved.
  3. Ensure proper PPE: chemical goggles, gloves, face shield, apron.
  4. Ensure aqueous waste or organic solvent is sent to ETP or recovery unit respectively.

5.4 Documentation

  1. Record:
    • Start and end time of separation
    • Volume/weight of each phase
    • Identification results
    • Final disposal/reprocessing path
  2. Use the “Phase Separation Logbook” (Annexure-2).
  3. Attach phase sample labels and retain for QA reference.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • BMR: Batch Manufacturing Record
  • QA: Quality Assurance
  • ETP: Effluent Treatment Plant

7. Documents

  1. Phase Sample Identification Form (Annexure-1)
  2. Phase Separation Logbook (Annexure-2)
  3. Drain Valve Inspection Checklist (Annexure-3)

8. References

  • ICH Q7 – GMP for Active Pharmaceutical Ingredients
  • 21 CFR Part 211 – cGMP for Finished Pharmaceuticals
  • WHO GMP Guidelines – Waste Management in Pharmaceutical Manufacturing
See also  API Manufacturing: SOP for Issuance of Raw Materials to Production - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Phase Sample Identification Form

Batch No. Phase Type Container ID Appearance Sampled By Test Result
API-202504 Aqueous CT-01 Clear Confirmed

Annexure-2: Phase Separation Logbook

Date Batch No. Start Time End Time Phase Separated Volume (L) Operator
13/04/2025 API-202504 10:30 11:15 Aqueous 200

Annexure-3: Drain Valve Inspection Checklist

Valve ID Date Inspected By Status Remarks
DV-05 13/04/2025 Functional No leaks

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2022 1.0 Initial Version New SOP Release QA Head
13/04/2025 2.0 Added Inspection Checklist & Safety Notes Process Improvement QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Tablets: SOP for QA Approval of In-Process Controls – V 2.0
Next Post: Creams: SOP for Handling Equipment Breakdowns during Cream Manufacturing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version